This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our and .
overview
Key Learning Objectives
- Understand basic concepts related to access to essential medicines, transparency, and the pharmaceutical value chain
- Understand different pharmaceutical pricing and reimbursement policies
- Understand the key components of Health technology assessment
- Explore methods of conducting an assessment
- Identifying strategies to ensure timely market access
- Formulary Management
About the Course
Whilst significant opportunities exist in emerging markets, the heterogeneous nature of pricing & reimbursement environment causes enormous uncertainty to commercial success. This interactive programme has been built to enable attendees navigate through such complex policies, reimbursement systems and competition in pharmaceutical industry globally with spotlight in Asian countries. To help you develop successful market access strategies, this leading masterclass brings together practical case studies of numerous drug segments, including orphan drugs, oncology, biosimilars, generics, OTC among others.
Who Will Benefit
- Pricing, Market Access Professionals who want to learn about regional markets
- Regulatory professionals who want to learn about commercial issues
- Strategic planners who want to know where they might go next
- Those who want insight into the way that markets influence each other
- Anyone who wants to understand global pricing issues
pricing
Course Outline
DAY 1
PHARMA PRICING – REIMBURSEMENT
- Introduction into reimbursement
- The pharmaceutical value chain
- Challenges for ensuring access to medicines
- Rationale for price regulations
- Pricing policies for new medicines and for generic and biosimilar medicines
Practical exercise
DAY 2
HEALTH TECHNOLOGY ASSESSMENT
- Introduction to HTA
- Core Concepts and Approaches to Early-Stage HTA
- Health Economics and Value Assessment Frameworks
- HTA High Versus Low-income Countries
- High-priced medicines, shortages, HTA
- Price regulation, and co-payment policies
- Projects and initiatives (e.g. WHO, Pharmaceutical Strategic for Europe, other regions)
Practical exercise
DAY 3
MARKET ACCESS
- The patterns in pricing & reimbursement systems and processes in different countries
- Market access challenges and opportunities
- Payers and the decision-making processes
- Who are the stakeholders across functions.
- Risk mitigation
Practical exercise
DAY 4
REGULATORY STRATEGIES
- HTA and Regulatory strategies
- Knowing the stakeholders
- Engaging with regulators
- Avoiding market access pitfalls
FORMULARY MANAGEMENT
- ASEAN case study
- Rational selection of products methodology
- How drug selection works at national, regional and hospital level
- Procurement models and consortian
- Final negotiations international aspects
- Strategic Pharma Pricing Roadmap
- ASEAN’s response to “Early Market Access”
Practical exercise
when & where
10 - 13 Sep 2024
Live Online Training
On-site & in-house training
Deliver this course how you want, where you want, when you want – and save up to 40%! 8+ employees seeking training on the same topic?
Talk to us about an on-site/in-house & customised solution.
contact
Still have a question?
Sushil Kunwar
Training Consultant
+61 (0)2 9080 4395
training@informa.com.au